fda warning bpc 157 safety status bpc-157 unapproved peptide FDA Targets GLP-1 and Peptide Compounding, Advertising and ' EVEXIAS Life Sciences filing lawsuit
Description
doi: 10.1021/acsomega.1c07218
Please ask your doctor about this
Liu HW, Chan YC, Wang MF, Wei CC, Chang SJ
Not all medications and nutrients are small enough to get absorbed or need breakdown via gastric enzymes for activation for the sublingual route, but whenever possible there is a benefit to using this route as it bypasses potential damage/absorption issues in the GI tract
It is worth noting that the short half-life does not mean the benefits are equally short-lived
Combining it with PRP (platelet-rich plasma) amplifies results through the vampire facial technique
